上海一飞生物科技有限公司 公司信息
公司名称:
上海一飞生物科技有限公司
电话:
021-65675885
电子邮件:
customer_service@efebio.com
国籍:
中国
网址:
http://www.efebio.com
产品总数:
11973
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
公司提供产品列表
Olinvacimab
2095504-49-5
RIP1 kinase inhibitor 1
2095515-38-9
(S)-ZINC-3573
2095596-11-3
Pozelimab
2096328-94-6
Tilavonemab
2096513-89-0
Spesolimab
2097104-58-8
HBED-CC-tris(tert-butyl ester)
2097123-80-1
Garetosmab
2097125-54-5
Pepinemab
2097151-87-4
Aneratrigine hydrochloride
2097163-75-0
BCL6-IN-7
2097518-46-0
OBI-3424
2097713-68-1
MLT-747
2097853-86-4
Anatibant 2HCl
209788-45-4
Stafib-2
2097938-74-2
I-138
2098211-50-6
USP1-IN-2
2098212-05-4
Budigalimab
2098225-93-3
Zampilimab
2098280-42-1
Nimacimab
2098636-09-8
Betrixaban-d6
2098655-51-5
Abelacimab
2098724-83-3
Sanguinarine citrate
2098782-69-3
Se-DMC
2098850-81-6
Lenumlostat
2098884-52-5
CDK4/6/1 Inhibitor
2099128-41-1
AT-121 hydrochloride
2099681-71-5
Bis-PEG4-t-butyl ester
2100306-53-2
CM03
2101208-44-8
Elipovimab
2101210-43-7
Cephalexin-d5
2101505-56-8
(R)-Pirtobrutinib
2101700-14-3
VU6000918
2101737-32-8
Glenzocimab
2101829-58-5
INT. 2
210193-42-3
Enpatoran hydrochloride
2101945-93-9
Envafolimab
2102192-68-5
MK-6884
2102194-04-5
LFHP-1c
2102347-47-5
Naph-EA-mal
210292-65-2
Taprizosin
210538-44-6
Narsoplimab
2108782-45-0
Edonentan
210891-04-6
Benufutamab
2109730-69-8
Orexin 2 Receptor Agonist 2
2114324-60-4
LY382884
211566-75-5
Lodapolimab
2118349-31-6
11-oxo-alpha-amyrin
2118-90-3
Teclistamab
2119595-80-9
3-OMFP Cyclohexylammonium salt
21233-09-0
Duostatin 5
2124210-34-8
Fianlimab
2126132-98-5
Telazorlimab
2126777-87-3
CYP4A11/CYP4F2-IN-2
2126874-77-7
SIRT5 inhibitor 3
2128651-12-5
Tetrahymanol
2130-17-8
BCL6-IN-8c
2130878-25-8
YW2036
2131223-92-0
Aurora kinase inhibitor-8
2133001-88-2
8-Azaguanosine
2133-80-4
Zastaprazan
2133852-18-1
Epcoritamab
2134641-34-0
Cantrixil
2135511-22-5
GSK3182571
2135595-04-7
Atoltivimab
2135632-29-8
Odesivimab
2135632-30-1
Maftivimab
2135632-36-7
(-)-JNJ-A07
2135640-92-3
(+)-JNJ-A07
2135640-93-4
DN401
2135749-60-7
SPOP-IN-6lc
2136270-56-7
Disitamab vedotin
2136633-23-1
Canocapavir
2137847-19-7
Vibecotamab
2138442-13-2
Plamotamab
2138442-31-4
Boc-NH-PEG4-C2-Boc
2138484-13-4
2-(3,4-Dihydroxyphenyl)-1,3-benzodioxole-5-carboxaldehyde
213903-67-4
AMPD2 inhibitor 1
2139356-35-5
Serclutamab
2140172-41-2
Prucalopride-13C-d3
2140306-00-7
Daminozide-d6 (dimethyl-d6)
2140327-55-3
RAGE 229
2143072-85-7
Olaparib-d5
2143107-56-4
MDH1-IN-1
2143463-31-2
MDH1-IN-2
2143463-35-6
Cirtuvivint
2143917-62-6
Pacmilimab
2145091-51-4
Praluzatamab
2145109-70-0
Diayangambin
21453-68-9
Bivatuzumab
214559-60-1
DS28120313
2146177-09-3
Efalizumab
214745-43-4
L-Cysteine-d3
214782-32-8
FmocNH-PEG4-t-butyl ester
2148295-94-5
Zalifrelimab
2148321-69-9
Tidutamab
2148354-90-7
Cendakimab
2151032-62-9
Ocarocoxib
215122-22-8
SC-75416
215122-74-0
MPT0G211
2151853-97-1
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
Copyright 2007© ChemicalBook. All rights reserved.